Atlas Copco AB Series A (0XXT)
London Exchange · UK · prices in SEK · close of 15 Oct 2026
Key indicators
| Last close | SEK 199.26 |
|---|---|
| 52-week range | 149.35 – 214.20 |
| Return, 1 month / 3 months | +3.1% / +6.6% |
| Return, 1 year / 3 years | +19.4% / +36.9% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 42 |
| Volatility (1 year) | 27.6% |
| Worst drawdown (1 year) | -20.0% |
| Average daily value traded | 443.64M SEK |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Atlas Copco is a Swedish industrial company that makes air compressors, vacuum pumps and air treatment equipment, along with power tools and assembly systems. Its customers are manufacturers, construction firms and other industrial businesses that rely on compressed air, gas and vacuum technology. The group also supplies mining and rock excavation equipment and provides service and maintenance for its machines. It is based in Stockholm, Sweden, and operates through a network of sales and service units in many countries.
On this site Atlas Copco AB Series A appears as a stock on the London Exchange (UK), code 0XXT, with prices in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Atlas Copco AB Series A (0XXT) trades on the London Exchange in UK. It last closed at SEK 199.26 on 15 October 2026.
Its price-based Market X-Ray is 75 out of 100 (a strong price profile), ranking 232 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 19.4% and over the last three months it rose 6.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 74 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 5.3% | ||
| From 52-week high | -6.6% | ||
| Momentum | 69 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 6.6% | ||
| 6-month return | 9.2% | ||
| 12-month return, skipping the last month | 15.8% | ||
| Stability (higher is calmer) | 71 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 27.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -20.0% | ||
| Liquidity | 95 · Strong | Trades actively. | |
| Average daily value traded | 443.64M SEK | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 4 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −3.1% |
|---|---|
| 1 month | +3.1% |
| 3 months | +6.6% |
| 6 months | +9.2% |
| 1 year | +19.4% |
| 3 years | +36.9% |
| 5 years | +57.5% |
Signals
| 50-day / 200-day average | 205.37 / 189.29 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 5.01 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 20 Oct 2025 | SEK 1.5000 |
| 30 Apr 2025 | SEK 1.5000 |
| 18 Oct 2024 | SEK 1.4000 |
| 25 Apr 2024 | SEK 1.4000 |
| 19 Oct 2023 | SEK 1.1500 |
| 28 Apr 2023 | SEK 1.1500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.